Published in Cancer Weekly, January 26th, 2010
"With a median follow-up of 105 months, the median progression-free survival was 61 months (95 % confidence interval, 53-77), and the median overall survival was 118 months (95 % confidence interval, 93-129). The 10- and 20-year progression-free and overall survival rate was 18 % and 0 % and 48 % and 22 %, respectively. Cox regression analysis...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.